Senior Director
Mirador Therapeutics
Senior Director
Mirador Therapeutics
Develops precision therapies for immune-mediated diseases
Mirador Therapeutics, Inc. is a clinical-stage precision medicine company focused on developing first-and/or best-in-class next-generation therapeutics for immunology and inflammation. The company’s Mirador360™ precision development engine leverages the latest advances in human genetics and data science to rapidly deliver new precision medicines for patients living with immune-mediated inflammatory and fibrotic diseases.
Mirador has raised over $650 million from leading life sciences investors and is based in San Diego, CA. Mirador was named Best Places to Work by Biospace and is a Fortune Best Small Workplaces™ and Fortune Best Workplaces in BioPharma™ for 2026.
Summary
The Senior Director, Clinical Pharmacology is accountable for the oversight and delivery of Mirador’s Phase 1 studies and serves as Study Director for several studies concurrently, from protocol concept through clinical study report. The position owns protocol authoring and amendments, the day-to-day sponsor interface with Phase 1 units and contract research organizations, and study-level budgets, timelines and vendor management, working in close partnership with Clinical Operations. The role also supports the operational regulatory documents that keep our INDs current (IND modules and amendments, annual reports and DSURs, and responses to health authority information requests) and contributes to the clinical pharmacology needs of later-phase programs and in-licensing diligence, including clinical pharmacology development plans and the recommended Phase 2 dose. The position reports to the Vice President, Early Clinical Development & Pharmacology.
We are seeking a hands-on early development leader who has carried programs rather than advised on them. This role provides the scientific and operational leadership that takes each study from a well-designed protocol to a clean, interpretable dataset. The incumbent is expected to apply pharmacokinetic/pharmacodynamic and model-informed drug development principles as needed to inform study design, dose selection, and data interpretation. The role works closely with Clinical Operations, R&D (biomarker and translational support), Medical Writing, Regulatory Affairs, Biostatistics and Data Management, and our external partners.
Responsibilities
Experience and Qualifications
Skills and Abilities
Job level may vary depending on experience and qualifications. The expected base pay range for this position is $250,000 - $300,000 plus bonus, equity, and comprehensive benefits. The base pay range reflects the target range for this position, but individual pay will be determined by additional factors such as job-related skills, experience and relevant education or training. This range may be modified in the future.
All qualified applicants are considered for employment without regard to race, color, religion, age, sex, sexual orientation, gender identity, national origin, disability, veteran status or other protected class.
#LI-remote
Working at Mirador Therapeutics | Great Place To Work®
All qualified applicants are considered for employment without regard to race, color, religion, age, sex, sexual orientation, gender identity, national origin, disability, veteran status or other protected class.
Read our Job Applicant Privacy Policy
Develops precision therapies for immune-mediated diseases
Mirador Therapeutics develops precision therapies for immune-mediated inflammatory and fibrotic diseases. The company uses advanced biology, multi-modal data, and analytics to create treatments that target specific immune pathways involved in these conditions. Its products work by modulating immune responses in a patient-specific way, with data guiding which patients are most likely to benefit from a given therapy. Mirador differentiates itself through its focus on precision medicine and data-driven design, led by former executives from Prometheus Biosciences, and by pursuing partnerships as well as direct commercialization. The goal is to improve patient outcomes by delivering targeted therapies that address the underlying immune mechanisms of inflammation and fibrosis.
Explore more opportunities at Mirador Therapeutics